Samsung Bioepis
- Biotech or pharma, therapeutic R&D
Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. Samsung Bioepis also strives to excel in biopharmaceutical industry by expanding to novel therapeutics such as ADC development and novel target/therapeutic discovery utilizing AI/ML
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}